PSB-CB5

• Description :

  PSB-CB5 is a potent and selective antagonist of GRP18. PSB-CB5 has the potential for the research of metabolic disease and obesity[1].

• UNSPSC :

  12352005

• Target :

  Cannabinoid Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Metabolic Disease

• Assay Protocol :

  https://www.medchemexpress.com/psb-cb5.html

• Purity :

  95.0

• Solubility :

  10 mM in DMSO|DMSO : ≥ 2mg/mL

• Smiles :

  O=C(N1C(SCCC1)=N/2)C2=C\C3=CC=CC(OCC4=CC=C(Cl)C=C4)=C3

• Molecular Formula :

  C20H17ClN2O2S

• Molecular Weight :

  384.88

• References & Citations :

  [1]Kotańska M, et al. Effects of GPR18 Ligands on Body Weight and Metabolic Parameters in a Female Rat Model of Excessive Eating. Pharmaceuticals (Basel) . 2021;14 (3) :270.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1627710-30-8]